Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from McKesson

Are Wall Street Analysts Predicting McKesson Stock Will Climb or Sink?

McKesson has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

Barchart

McKesson Q4 Earnings Call Highlights

McKesson (NYSE:MCK) reported a stronger fiscal fourth quarter and full fiscal 2026 performance, with executives pointing to growth across its oncology, multispecialty, pharmaceutical distribution and prescription technology businesses, while outlining plans for continued earnings growth in fiscal 20

MarketBeat

McKesson Earnings Preview: What to Expect

McKesson is expected to unveil its fourth-quarter results next month, and analysts are projecting a double-digit profit increase.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Stocks That Could Be Next to Announce a Stock Split

Stock splits often follow strong growth. Here are three high-priced stocks that could be candidates for a stock split in 2026

MarketBeat

3 Dividend Growth Stocks Quietly Raising Payouts

Despite not having the highest dividend yields, these three firms may draw attention for their history of dividend growth and their strong overall performance.

MarketBeat

Is McKesson Corporation Stock Outperforming the Nasdaq?

McKesson shows strong relative performance, with analysts maintaining a bullish outlook on its stock.

Barchart

Is Wall Street Bullish or Bearish on McKesson Stock?

McKesson has outperformed the broader market over the past year, and analysts remain highly bullish about the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Stocks Sink With Alphabet, Bitcoin: Stock Market Today

A dismal round of jobs data did little to lift sentiment on Thursday.

Kiplinger

Texas man dies after pharmacy gives him another patient’s medication, lawsuit says

Exclusive: Joseph Hamilton Broussard took the meds as directed, but he had received the wrong ones, the 91-year-old’s daughter alleges

The Independent UK

Is McKesson Corporation Stock Outperforming the S&P 500?

McKesson has outstripped the S&P 500 Index's rally over the past year, igniting analysts’ unflinching optimism about the healthcare stock's steadfast, upward trajectory.

Barchart

Digital Tools That Will Improve Your Workflow Efficiency

In today’s fast-moving digital world, growth depends on more than hard work—it relies on the tools you choose. Whether you’re running marketing campaigns, tracking performance, automating repeatable tasks, or improving the way customers interact with your brand, the right digital setup can separate successful teams from those that struggle to…

inkl

Are Wall Street Analysts Bullish on McKesson Stock?

McKesson has outpaced the broader market returns over the past year, and analysts remain upbeat on MCK, noting the company’s reliable growth momentum and supportive earnings outlook.

Barchart

This ‘Strong Buy’ Healthcare Stock Just Hit New All-Time Highs

McKesson (MCK) is trading at new all-time highs and has strong technical momentum. MCK has a 100% “Buy” opinion from Barchart. Shares are up nearly 60% over the past year. Analyst sentiment is overwhelmingly positive, with multiple “Strong Buy” ratings and price targets up to $984, despite some valuation concerns....

Barchart

What to Expect From McKesson's Next Quarterly Earnings Report

McKesson is expected to announce its second-quarter results next month, and analysts predict a double-digit increase in the company’s bottom-line figure.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

The Saturday Spread: Picking Out Empirically Intriguing Stocks Potentially Due for a Comeback (MCK, HON, AKAM)

It’s been another eventful week in the markets. These three stocks just might add some more excitement for contrarian bulls.

Barchart

How Is McKesson's Stock Performance Compared to Other Health Care Services Stocks?

McKesson has outperformed the Health Care Services industry over the past year, and analysts are highly optimistic about the stock’s prospects.

MarketBeat

More Than Yield: 5 Stocks Beating the Market and Hiking Dividends

Check out these five stocks that are beating the market in 2025 and just announced dividend increases of between 10% and 15%.

Barchart

What to Expect From McKesson's Q1 2026 Earnings Report

McKesson is all set to release its fiscal first-quarter earnings next month, and analysts project a single-digit earnings growth.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

McKesson Stock: Is Wall Street Bullish or Bearish?

As McKesson has outpaced the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart

This Stock Rallied to a New Record High Ahead of Today’s Earnings Report

McKesson (MCK) edged to a new record high on Wednesday, taking out its previous record high posted about a month ago on April 4. McKesson rallied going into today’s after-market earnings report, raising the bar for earnings performance. With today’s report, there is the likelihood of volatility. The options market...

MarketBeat

3 Safe Dividend Stocks as Investors Seek to Reset Diversification

Investors have been reminded that low growth is better than no growth; here are three dividend stocks that can provide shelter in the current storm

MarketBeat

3 Stocks to Consider With a Possible Recession on the Table

As recession indicators begin to flash, investors may turn to defensive plays for protection—these three stocks offer a compelling case for sturdiness.

Barchart

Is McKesson Stock Outperforming the Dow?

As McKesson has outperformed the Dow Jones over the past year, analysts are bullish about the stock’s prospects.

MarketBeat

These 3 Stocks Are Generating Massive Returns on Capital

Take a gander at these three stocks that are generating returns on invested capital (ROIC) that are among the best in the U.S. large-cap stock universe.

Barchart

McKesson Stock: Analyst Estimates & Ratings

McKesson has underperformed relative to the S&P 500 Index over the past year, but Wall Street analysts remain bullish on its growth prospects.

1 2 3 4

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.